Aegis Capital analyst Nathan Weinstein reiterated a Buy rating and $8.00 price target on atai Life Sciences N.V (NASDAQ: ATAI).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE